GALWAY, Ireland--(BUSINESS WIRE)--Aerogen, the global leader in aerosol drug delivery, today announced details of a broad collaborative effort to support pharmaceutical companies from around the world ...

GALWAY, Ireland--(BUSINESS WIRE)--Swedish based Maquet Critical Care and Aerogen, Ireland, have today announced the release of their partnered product, an integrated unit which provides state of the ...

Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The "United States Nebulizer Market Report by Type, Modality, Applications, End Use, States and Company Analysis, 2025-2033" report has been added to ...

Aerogen, a specialty pharmaceutical company, develops products based on its OnQ (TM) Aerosol Generator technology to improve the treatment of respiratory disorders in the acute care setting. Aerogen ...

Cansino Biologics Inc. has entered a development and commercial supply partnership with Aerogen Ltd. for an inhalable version of its COVID-19 vaccine, Convidecia, also known as Ad5-nCoV. Cansino will ...

Aerogen Inc announced the results of its Phase II clinical study using the Aerodose albuterol inhaler at The American College of Chest Physicians conference in Philadelphia. The results of the study ...

The global nebulizers market was valued at US$ 1 billion in 2020. It is estimated to expand at a CAGR of 6.6% from 2021 to 2028, reaching approximately US$ 1.7 billion by the end of 2028. The ...

Synairgen's SNG001 among the many potential treatments and vaccines to be delivered via Aerogen's aerosol drug delivery system Adds to the thousands of COVID-19 patients already safely and effectively ...

(MENAFN- GlobeNewsWire - Nasdaq) The United States nebulizer market is set to grow from US$ 466.55 million in 2024 to US$ 730.62 million by 2033, with a CAGR of 5.11%. This growth is driven by the ...